Drug Shortage Report for METHOTREXATE SODIUM INJECTION
Report ID | 87676 |
Drug Identification Number | 02099705 |
Brand name | METHOTREXATE SODIUM INJECTION |
Common or Proper name | METHOTREXATE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | METHOTREXATE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS INTRACEREBROVENTRICULAR |
Packaging size | 2ML |
ATC code | L01BA |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-06-27 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2019-08-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-08-07 | French | Compare |
v5 | 2019-08-07 | English | Compare |
v4 | 2019-06-28 | English | Compare |
v3 | 2019-06-27 | French | Compare |
v2 | 2019-06-27 | English | Compare |
v1 | 2019-06-27 | English | Compare |
Showing 1 to 6 of 6